Knight Therapeutics | GUD - Ordinary Share Capital



Knight Therapeutics reported CAD539.32M in Ordinary Share Capital for its fiscal quarter ending in September of 2024.


Ordinary Share Capital Change Date
Acasti Pharma USD 1000 261.04M Dec/2024
Alaunos Therapeutics USD 2K 0 Dec/2024
Aurora Cannabis CAD 56.25M 6.92B Jun/2025
Canopy Growth CAD 205.15M 8.47B Jun/2025
Cronos Group USD 383.81M 285.23M Jun/2025
Dianthus Therapeutics USD 32.18M 32.15M Jun/2025
Ionis Pharmaceuticals USD 159.2M 159.04M Jun/2025
IQVIA Holdings USD 170M 167.42M Jun/2025
Knight Therapeutics CAD 539.32M 1.63M Sep/2024
Moderna USD 389M 388.96M Jun/2025
Organigram Holdings CAD 134.02M 758.57M Jun/2025
Organon & Co USD 259.96M 256.96M Jun/2025
Revvity USD 117.87M 2.78M Jun/2025
Tectonic Therapeutic USD 18.71M 18.71M Jun/2025
Tilray USD 93K 5K Nov/2024
Viatris USD 1.17B 1.15B Jun/2025
Xeris Pharmaceuticals USD 161.22M 161.21M Jun/2025